Minnesota Community Networks Center for Eliminating Cancer Disparities: Cervical Cancer Screening Project Part C Quantitative
The trial will pilot text a protocol for home vaginal bio-specimen collection for human
papillomavirus (HPV) testing for cervical cancer screening. The main objective is to
estimate the successful screening completion rate among a sample of Somali women who have
not undergone cervical cancer screening for three or more years. Women will be randomized to
either home vaginal bio-specimen collection or referral to undergo a clinic-based Pap test.
Observational Model: Cohort, Time Perspective: Prospective
Number of home vaginal bio-specimen collections compared to standard clinic-based Pap test
The main outcome will be successful completion of cervical cancer screening by 3 months after enrollment. For the Home Vaginal Biospecimen Collection Group, completion is defined as return of the HPV DNA self-sampling kit by the patient, with a sample suitable for laboratory analysis. In the Clinic Pap Test Group, completion is defined by documentation of Pap test result.
Within 3 months after Enrollment
Rahel Ghebre, M.D.
Masonic Cancer Center, University of Minnesota
United States: Institutional Review Board
|Masonic Cancer Center, University of Minnesota||Minneapolis, Minnesota 55455|